
Podcast #517 · 14 Feb 2025
Complex HCC Patients & The "Grey Zone": What To Do When You Don’t Know What To Do
- Hepatocellular Carcinoma (HCC)
- Chemotherapy
- Interventional Radiology (IR)
- Gastrointestinal Cancer
- Cholangiocarcinoma
- Immunotherapy
- Tumor Board
- Y90 Radioembolization
- Medical Oncology
- Interventional Oncology (IO)
Treatment of hepatocellular carcinoma (HCC), like that of many other cancers, spans a spectrum from curative to palliative intent. To explore the "grey zone" of treatment goals for intermediate-stage HCC patients, Dr. Sabeen Dhand interviews a panel of experts in the field: medical oncologists Dr. Adam Burgoyne and Dr. Lingling Du, along with interventional radiologists Dr. Kirema Garcia-Reyes and Dr. Zachary Berman.
This podcast is supported by an educational grant from AstraZeneca Pharmaceuticals and Boston Scientific.

